Prion diseases and their biochemical mechanisms

Biochemistry

Volumn 48, Issue 12, 2009, Pages 2574-2585

  Cobb, Nathan J ^a,b   Surewicz, Witold K ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MECHANISMS; CELLULAR PRION PROTEINS; CONFORMATIONAL CONVERSIONS; INFECTIOUS AGENTS; MISFOLDED PROTEINS; MOLECULAR BASIS; NEURODEGENERATIVE DISORDERS; PRION DISEASE; PRION PROTEINS; STRUCTURAL KNOWLEDGE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES;

MAMMALS; NUCLEIC ACIDS; SCANDIUM;

PROTEINS;

AMINO ACID; AMYLOID; GLYCOSYLPHOSPHATIDYLINOSITOL; PRION PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BIOCHEMICAL COMPOSITION; BRAIN SPONGIOSIS; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FUNGAL COMMUNITY; FUNGUS; IN VITRO STUDY; INTESTINE EPITHELIUM; LIPID RAFT; MAMMAL; MEDICAL RESEARCH; MICROBIAL DIVERSITY; MOLECULAR BIOLOGY; NERVE DEGENERATION; NEUROTOXICITY; NITROGEN METABOLISM; NONHUMAN; PATHOGENICITY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; STRAIN IDENTIFICATION; TRANSCYTOSIS; VIRUS; YEAST;

ANIMALS; FUNGAL PROTEINS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PRION DISEASES; PROTEIN CONFORMATION; PROTEIN FOLDING; PRPSC PROTEINS;

ANIMALIA; FUNGI; MAMMALIAN PRION;

EID: 65249161100     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900108v     Document Type: Article

References (98)

1. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
2. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383.
3. Caughey, B., and Chesebro, B. (2001) Transmissible spongiform encephalopathies and prion protein interconversions. Adv. Virus Res. 56, 277-311.
4. Collinge, J. (2001) Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550.
5. Aguzzi, A., and Polymenidou, M. (2004) Mammalian prion biology: One century of evolving concepts. Cell 116, 313-327.
6. Weissmann, C. (2004) The state of the prion. Nat. Rev. Microbiol. 2, 861-871.
7. Mabbott, N. A., and MacPherson, G. G. (2006) Prions and their lethal journey to the brain. Nat. Rev. Microbiol. 4, 201-211.
8. Wells, G. A., and Wilesmith, J. W. (1995) The neuropathology and epidemiology of bovine spongiform encephalopathy. Brain Pathol. 5, 91-103.
9. Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) A cellular gene encodes scrapie PrP 27- 30 protein. Cell 40, 735-746.
10. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M., and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
11. Wickner, R. B., Edskes, H. K., Roberts, B. T, Baxa, U., Pierce, M. M., Ross, E. D., and Brachmann, A. (2004) Prions: Proteins as genes and infectious entities. Genes Dev. 18, 470-485.
12. Uptain, S. M., and Lindquist, S. (2002) Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703-741.
13. Chien, P., Weissman, J. S., and DePace, A. H. (2004) Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73, 617-656.
14. Legname, G., Baskakov, I. V., Nguyen, H. O., Riesner, D., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. (2004) Synthetic mammalian prions. Science 305, 673-676.
15. Castilla, J., Saa, P., Hetz, C., and Soto, C. (2005) In vitro generation of infectious scrapie prions. Cell 121, 195-206.
16. Deleault, N. R., Harris, B. T, Rees, J. R., and Supattapone, S. (2007) Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U.S.A. 104, 9741-9746.
17. Wuthrich, K., and Riek, R. (2001) Three-dimensional structures of prion proteins. Adv. Protein Chem. 57, 55-82.
18. Millhauser, G L. (2004) Copper binding in the prion protein. Acc. Chem. Res. 37, 79-85.
19. Choi, C. J., Kanthasamy, A., Anantharam, V., and Kanthasamy, A. G (2006) Interaction of metals with prion protein: Possible role of divalent cations in the pathogenesis of prion diseases. Neuro-toxicology 27, 777-787.
20. Caughey, B., and Baron, G. S. (2006) Prions and their partners in crime. Nature 443, 803-810.
21. Westergard, L., Christensen, H. M., and Harris, D. A. (2007) The cellular prion protein (PrP(C)): Its physiological function and role in disease. Biochim. Biophys. Acta 1772, 629-644.
22. Watts, J. C, and Westaway, D. (2007) The prion protein family: Diversity, rivalry, and dysfunction. Biochim. Biophys. Acta 1772, 654-672.
23. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., and Caughey, B. (2005) The most infectious prion protein particles. Nature 437, 257-261.
24. Caughey, B., and Lansbury, P. T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298.
25. Chiti, F., and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366.
26. Tycko, R. (2004) Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14, 96-103.
27. Du, Z., Park, K. W., Yu, H., Fan, Q., and Li, L. (2008) Newly identified prion linked to the chromatin-remodeling factor Swil in Saccharomyces cerevisiae. Nat. Genet. 40, 460-465.
28. Tanaka, M., Chien, P., Naber, N, Cooke, R., and Weissman, J. S. (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323-328.
29. King, C. Y., and Diaz-Avalos, R. (2004) Protein-only transmission of three yeast prion strains. Nature 428, 319-323.
30. Coustou, V., Deleu, C, Saupe, S., and Begueret, J. (1997) The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. U.S.A. 94, 9773-9778.
31. Tanaka, M., Collins, S. R., Toyama, B. H., and Weissman, J. S. (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585-589.
32. Walker, L. C, Callahan, M. J., Bian, F., Durham, R. A., Roher, A. E., and Lipinski, W. J. (2002) Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice. Peptides 23, 1241-1247.
33. Xing, Y., Nakamura, A., Chiba, T, Kogishi, K, Matsushita, T, Li, F., Guo, Z., Hosokawa, M., Mori, M., and Higuchi, K. (2001) Transmission of mouse senile amyloidosis. Lab. Invest. 81, 493-499.
34. Korenaga, T, Yan, J., Sawashita, J., Matsushita, T, Naiki, H., Hosokawa, M., Mori, M., Higuchi, K, and Fu, X. (2006) Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am. J. Pathol. 168, 898-906.
35. Zhang, B., Une, Y., Fu, X., Yan, J., Ge, F., Yao, J., Sawashita, J., Mori, M., Tomozawa, H., Kametani, F., and Higuchi, K (2008) Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl. Acad. Sci. U.S.A. 105, 7263-7268.
36. Heikenwalder, M., Julius, C, and Aguzzi, A. (2007) Prions and peripheral nerves: A deadly rendezvous. J. Neurosci. Res. 85, 2714-2725.
37. Mishra, R. S., Basu, S., Gu, Y., Luo, X., Zou, W. Q., Mishra, R., Li, R., Chen, S. G., Gambetti, P., Fujioka, H., and Singh, N. (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: Implications for species barrier in prion uptake from the intestine. J. Neurosci. 24, 11280-11290.
38. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C, and Aguzzi, A. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343.
39. Chiesa, R., Piccardo, P., Quaglio, E., Drisaldi, B., Si-Hoe, S. L., Takao, M., Ghetti, B., and Harris, D. A. (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77, 7611-7622.
40. Nazor, K E., Kuhn, F., Seward, T, Green, M., Zwald, D., Purro, M., Schmid, J., Biffiger, K, Power, A. M., Oesch, B., Raeber, A. J., and Telling, G. C. (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 24, 2472-2480.
41. Chesebro, B., Trifilo, M., Race, R., Meade-White, K, Teng, C, LaCasse, R., Raymond, L., Favara, C, Baron, G., Priola, S., Caughey, B., Masliah, E., and Oldstone, M. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439.
42. Ratte, S., Prescott, S. A., Collinge, J., and Jefferys, J. G (2008) Hippocampal bursts caused by changes in NMDA receptordependent excitation in a mouse model of variant CJD. Neurobiol. Dis. 32, 96-104.
43. LaCasse, R. A., Striebel, J. F., Favara, C, Kercher, L., and Chesebro, B. (2008) Role of Erk1/2 activation in prion disease pathogenesis: Absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J. Neuroimmunol. 196, 16-26.
44. Prusiner, S. B. (1991) Molecular biology of prion diseases. Science 252, 1515-1522.
45. Maiti, N. R., and Surewicz, W. K. (2001) The role of disulfide bridge in the folding and stability of the recombinant human prion protein. J. Biol. Chem. 276, 2427-2431.
46. Jarrett, J. T., and Lansbury, P. T., Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
47. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T., and Caughey, B. (1994) Cell-free formation of protease-resistant prion protein. Nature 370, 471-474.
48. Horiuchi, M., and Caughey, B. (1999) Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203.
49. Caughey, B. (2001) Interactions between prion protein isoforms: The kiss of death? Trends Biochem. Sci. 26, 235-242.
50. Saborio, G. P., Permanne, B., and Soto, C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813.
51. Hornemann, S., Schorn, C, and Wuthrich, K. (2004) NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep. 5, 1159-1164.
52. Swietnicki, W., Morillas, M., Chen, S. G., Gambetti, P., and Surewicz, W. K. (2000) Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39, 424-431.
53. Lee, S., and Eisenberg, D. (2003) Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat. Struct. Biol. 10, 725-730.
54. Knaus, K. J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W. K., and Yee, V. C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8, 770-774.
55. Baskakov, I. V. (2004) Autocatalytic conversion of recombinant prion proteins displays a species barrier. J. Biol. Chem. 279, 7671-7677.
56. Stohr, J., Weinmann, N, Wille, H., Kaimann, T., Nagel-Steger, L., Birkmann, E., Panza, G., Prusiner, S. B., Eigen, M., and Riesner, D. (2008) Mechanisms of prion protein assembly into amyloid. Proc. Natl. Acad. Sci. U.S.A. 105, 2409-2414.
57. Bocharova, O. V., Breydo, L., Salnikov, V. V., Gill, A. C, and Baskakov, I. V. (2005) Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci. 14, 1222-1232.
58. Cobb, N. J., Sonnichsen, F. D., McHaourab, H., and Surewicz, W. K. (2007) Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure. Proc. Natl. Acad. Sci. U.S.A. 104, 18946-18951.
59. Lu, X., Wintrode, P. L., and Surewicz, W. K. (2007) β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/ deuterium exchange. Proc. Natl. Acad. Sci. U.S.A. 104, 1510-1515.
60. Cobb, N. J., Apetri, A. C, and Surewicz, W. K. (2008) Prion Protein Amyloid Formation under Native-like Conditions Involves Refolding of the C-terminal a-Helical Domain. J. Biol. Chem. 283, 34704-34711.
61. Padrick, S. B., and Miranker, A. D. (2002) Islet amyloid: Phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41, 4694-4703.
62. Collins, S. R., Douglass, A., Vale, R. D., and Weissman, J. S. (2004) Mechanism of prion propagation: Amyloid growth occurs by monomer addition. PLoS Biol. 2, e321.
63. Wildegger, G., Liemann, S., and Glockshuber, R. (1999) Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat. Struct. Biol. 6, 550-553.
64. Apetri, A. C, Maki, K., Roder, H., and Surewicz, W. K. (2006) Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J. Am. Chem. Soc. 128, 11673- 11678.
65. Apetri, A. C, and Surewicz, W. K. (2002) Kinetic intermediate in the folding of human prion protein. J. Biol. Chem. 277, 44589-44592.
66. Nicholson, E. M., Mo, H., Prusiner, S. B., Cohen, F. E., and Marqusee, S. (2002) Differences between the prion protein and its homolog Doppel: A partially structured state with implications for scrapie formation. J. Mol. Biol. 316, 807-815.
67. Kuwata, K., Li, H., Yamada, H., Legname, G., Prusiner, S. B., Akasaka, K., and James, T. L. (2002) Locally disordered conformer of the hamster prion protein: A crucial intermediate to PrPSc? Biochemistry 41, 12277-12283.
68. Apetri, A. C, Surewicz, K., and Surewicz, W. K. (2004) The effect of disease-associated mutations on the folding pathway of human prion protein. J. Biol. Chem. 279, 18008-18014.
69. Taraboulos, A., Rogers, M., Borchelt, D. R., McKinley, M. P., Scott, M., Serban, D., and Prusiner, S. B. (1990) Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc. Natl. Acad. Sci. U.S.A. 87, 8262-8266.
70. Atarashi, R., Moore, R. A., Sim, V. L., Hughson, A. G., Dorward, D. W., Onwubiko, H. A., Priola, S. A., and Caughey, B. (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4, 645-650.
71. Nelson, R., Sawaya, M. R., Balbirnie, M., Madsen, A. O., Riekel, C, Grothe, R., and Eisenberg, D. (2005) Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773-778.
72. Sawaya, M. R., Sambashivan, S., Nelson, R., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J., McFarlane, H. T., Madsen, A. O., Riekel, C, and Eisenberg, D. (2007) Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453-457.
73. Wickner, R. B., Shewmaker, F., Kryndushkin, D., and Edskes, H. K. (2008) Protein inheritance (prions) based on parallel in-register β-sheet amyloid structures. BioEssays 30, 955-964.
74. Krishnan, R., and Lindquist, S. L. (2005) Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435, 765-772.
75. Petkova, A. T, Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265.
76. Margittai, M., and Langen, R. (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: Molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41, 265-297.
77. Wasmer, C, Lange, A., Van Melckebeke, H., Siemer, A. B., Riek, R., and Meier, B. H. (2008) Amyloid fibrils of the HET-s(218- 289) prion form a β solenoid with a triangular hydrophobic core. Science 319, 1523-1526.
78. Govaerts, C, Wille, H., Prusiner, S. B., and Cohen, F. E. (2004) Evidence for assembly of prions with left-handed β-helices into trimers. Proc. Natl. Acad. Sci. U.S.A. 101, 8342-8347.
79. DeMarco, M. L., and Daggett, V. (2004) From conversion to aggregation: Protofibril formation of the prion protein. Proc. Natl. Acad. Sci. U.S.A. 101, 2293-2298.
80. Kimberlin, R. H., and Walker, C. A. (1979) Pathogenesis of scrapie: Agent multiplication in brain at the first and second passage of hamster scrapie in mice. J. Gen. Virol. 42, 107-117.
81. Scott, M., Foster, D., Mirenda, C, Serban, D., Coufal, F., Walchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. J., et al. (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847-857.
82. Prusiner, S. B., Scott, M., Foster, D., Pan, K. M., Groth, D., Mirenda, C, Torchia, M., Yang, S. L., Serban, D., Carlson, G. A., et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686.
83. Kocisko, D. A., Priola, S. A., Raymond, G. J., Chesebro, B., Lansbury, P. T., Jr., and Caughey, B. (1995) Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc. Natl. Acad. Sci. U.S.A. 92, 3923-3927.
84. Priola, S. A., and Chesebro, B. (1995) A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69, 7754-7758.
85. Bessen, R. A., and Marsh, R. F. (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859-7868.
86. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., and Prusiner, S. B. (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157- 1165.
87. Caughey, B., Raymond, G. J., and Bessen, R. A. (1998) Strain-dependent differences in β-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230-32235.
88. Peretz, D., Williamson, R. A., Legname, G, Matsunaga, Y., Vergara, J., Burton, D. R., DeArmond, S. J., Prusiner, S. B., and Scott, M. R. (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34, 921-932.
89. Toyama, B. H., Kelly, M. J., Gross, J. D., and Weissman, J. S. (2007) The structural basis of yeast prion strain variants. Nature 449, 233-237.
90. Jones, E. M., and Surewicz, W. K. (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121, 63-72.
91. Makarava, N., and Baskakov, I. V. (2008) The same primary structure of the prion protein yields two distinct self-propagating states. J. Biol. Chem. 283, 15988-15996.
92. Nishina, K. A., Deleault, N. R., Mahal, S. P., Baskakov, I., Luhrs, T, Riek, R., and Supattapone, S. (2006) The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45, 14129-14139.
93. Collinge, J., and Clarke, A. R. (2007) A general model of prion strains and their pathogenicity. Science 318, 930-936.
94. Vanik, D. L., Surewicz, K. A., and Surewicz, W. K. (2004) Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139-145.
95. Bartz, J. C, Bessen, R. A., McKenzie, D., Marsh, R. F., and Aiken, J. M. (2000) Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J. Virol. 74, 5542-5547.
96. Tanaka, M., Chien, P., Yonekura, K., and Weissman, J. S. (2005) Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121, 49-62.
97. Castilla, J., Gonzalez-Romero, D., Saa, P., Morales, R., De Castro, J., and Soto, C. (2008) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134, 757-768.
98. Polymenidou, M., Stoeck, K., Glatzel, M., Vey, M., Bellon, A., and Aguzzi, A. (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4, 805-814.